Cargando…
LOX-1 and cancer: an indissoluble liaison
Recently, a strong correlation between metabolic disorders, tumor onset, and progression has been demonstrated, directing new therapeutic strategies on metabolic targets. OLR1 gene encodes the LOX-1 receptor protein, responsible for the recognition, binding, and internalization of ox-LDL. In the pas...
Autores principales: | Murdocca, M., De Masi, C., Pucci, S., Mango, R., Novelli, G., Di Natale, C., Sangiuolo, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571092/ https://www.ncbi.nlm.nih.gov/pubmed/33402733 http://dx.doi.org/10.1038/s41417-020-00279-0 |
Ejemplares similares
-
Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model
por: Murdocca, Michela, et al.
Publicado: (2019) -
Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019) -
LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies
por: Rizzacasa, Barbara, et al.
Publicado: (2017) -
Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer
por: Murdocca, Michela, et al.
Publicado: (2021) -
The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer
por: Murdocca, Michela, et al.
Publicado: (2016)